National Academies Press: OpenBook

Global Health Risk Framework: Research and Development of Medical Products: Workshop Summary (2016)

Chapter: Appendix A: References

Get This Book
Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF.
« Previous: 8 Crosscutting Themes and Closing Remarks
Page 87 Cite
Suggested Citation:"Appendix A: References." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Research and Development of Medical Products: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21853.
×
Save
Cancel

A

References

Abe, S. 2013. Japan’s strategy for global health diplomacy: Why it matters. Lancet 382(9896):915-916.

Adebamowo, C., O. Bah-Sow, F. Binka, R. Bruzzone, A. Caplan, J. F. Delfraissy, D. Heymann, P. Horby, P. Kaleebu, J. J. Tamfum, P. Olliaro, P. Piot, A. Tejan-Cole, O. Tomori, A. Toure, E. Torreele, and J. Whitehead. 2014. Randomised controlled trials for Ebola: Practical and ethical issues. Lancet 384:1423-1424.

Bhan, M. K., R. I. Glass, K. M. Ella, N. Bhandari, J. Boslego, H. B. Greenberg, K. Mohan, G. Curlin, and T. S. Rao. 2014. Team science and the creation of a novel rotavirus vaccine in India: A new framework for vaccine development. Lancet 383(9935):2180-2183.

Bhandari, N., T. Rongsen-Chandola, A. Bavdekar, J. John, K. Antony, S. Taneja, N. Goyal, A. Kawade, G. Kang, S. S. Rathore, S. Juvekar, J. Muliyil, A. Arya, H. Shaikh, V. Abraham, S. Vrati, M. Proschan, R. Kohberger, G. Thiry, R. Glass, H. B. Greenberg, G. Curlin, K. Mohan, G. V. Harshavardhan, S. Prasad, T. S. Rao, J. Boslego, M. K. Bhan, and the India Rotavirus Vaccine Group. 2014. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: A randomised, double-blind, placebo-controlled trial. Lancet 383(9935):2136-2143.

Borio, L., E. Cox, and N. Lurie. 2015. Combating emerging threats—accelerating the availability of medical therapies. New England Journal of Medicine 373(11):993-995.

Cox, E., L. Borio, and R. Temple. 2014. Evaluating Ebola therapies—the case for RCTs. New England Journal of Medicine 371(25):2350-2351.

De Gregorio, E., and R. Rappuoli. 2014. From empiricism to rational design: A personal perspective of the evolution of vaccine development. Nature Reviews Immunology 14(7):505-514.

Fineberg, H. V. 2015. Pandemic preparedness and response—lessons from the H1N1 influenza of 2009. In Emerging viral diseases: The One Health connection: Workshop summary. Washington, DC: The National Academies Press. Pp. 152-165.

IOM (Institute of Medicine). 2015a. Rapid medical countermeasure response to infectious diseases: Enabling sustainable capabilities through ongoing public- and private-sector partnerships: Workshop summary. Washington, DC: The National Academies Press.

Page 88 Cite
Suggested Citation:"Appendix A: References." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Research and Development of Medical Products: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21853.
×
Save
Cancel

IOM. 2015b. Sharing clinical trial data: Maximizing benefits, minimizing risk. Washington, DC: The National Academies Press.

Jaffe, K., M. Caicedo, M. Manzanares, M. Gil, A. Rios, A. Florez, C. Montoreano, and V. Davila. 2013. Productivity in physical and chemical science predicts the future economic growth of developing countries better than other popular indices. PLoS ONE 8(6):e66239.

Levine, M. M., M. Tapia, A. V. Hill, and S. O. Sow. 2015. How the current West African Ebola virus disease epidemic is altering views on the need for vaccines and is galvanizing a global effort to field-test leading candidate vaccines. Journal of Infectious Diseases 211(4):504-507.

Pedrique, B., N. Strub-Wourgaft, C. Some, P. Olliaro, P. Trouiller, N. Ford, B. Pécoul, and J. H. Bradol. 2013. The drug and vaccine landscape for neglected diseases (2000-11): A systematic assessment. Lancet Global Health 1(6):e371-e379.

Plotkin, S. A., A. A. Mahmoud, and J. Farrar. 2015. Establishing a global vaccine-development fund. New England Journal of Medicine 373(4):297-300.

Page 87 Cite
Suggested Citation:"Appendix A: References." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Research and Development of Medical Products: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21853.
×
Save
Cancel
Page 87
Page 88 Cite
Suggested Citation:"Appendix A: References." National Academies of Sciences, Engineering, and Medicine. 2016. Global Health Risk Framework: Research and Development of Medical Products: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21853.
×
Save
Cancel
Page 88
Next: Appendix B: Workshop Statement of Task »
Global Health Risk Framework: Research and Development of Medical Products: Workshop Summary Get This Book
×
Global Health Risk Framework: Research and Development of Medical Products: Workshop Summary
Buy Paperback | $45.00 Buy Ebook | $35.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Since the 2014 Ebola outbreak many public- and private-sector leaders have seen a need for improved management of global public health emergencies. The effects of the Ebola epidemic go well beyond the three hardest-hit countries and beyond the health sector. Education, child protection, commerce, transportation, and human rights have all suffered. The consequences and lethality of Ebola have increased interest in coordinated global response to infectious threats, many of which could disrupt global health and commerce far more than the recent outbreak.

In order to explore the potential for improving international management and response to outbreaks the National Academy of Medicine agreed to manage an international, independent, evidence-based, authoritative, multistakeholder expert commission. As part of this effort, the Institute of Medicine convened four workshops in summer of 2015 to inform the commission report. The presentations and discussions from the Workshop on Research and Development of Medical Products are summarized in this report.

READ FREE ONLINE

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!